Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
A majority of the elderly patients undergo surgery for malignant tumors. For these patients,
postoperative tumor recurrence and metastasis are main factors that worsen long-term
outcomes. The investigators hypothesize that dexmedetomidine supplemented analgesia in
elderly patients after cancer surgery may help to maintain immune function and improve
long-term outcomes, possibly by relieving stress and inflammatory response, improving
analgesic efficacy and sleep quality, and reducing delirium incidence.
Phase:
N/A
Details
Lead Sponsor:
Peking University First Hospital
Collaborators:
Affiliated Hospital of Hebei University Beijing Chao Yang Hospital Beijing Ditan Hospital Beijing Shijitan Hospital, Capital Medical University Beijing Tsinghua Chang Gung Hospital Guizhou Provincial People's Hospital Peking University International Hospital Qingdao Municipal Hospital Shanxi Provincial Cancer Hospital The Second Affiliated Hospital of Air Force Medical University The Third Xiangya Hospital of Central South University Tianjin Hospital of ITCWM-Nankai Hospital Zhongda Hospital Southeast University